Newsfeeds - Spark Newswire

1 minute read

Tetra Bio-Pharma Signs License Agreement With Thorne Health Tech For A Prebiotic Dietary Supplement

Today, 8:37 PM

Tetra Bio-Pharma Inc (TSX:TBP) (OTCQB: TBPMF) (FRA: JAM1), cannabinoid-based drug developer, has signed a licensing agreement with Thorne Health Tech, Inc. (NASDAQ: THRN) for the commercialization of its patent

TBPMF

1 minute read

Thorne HealthTech Joins Hand With Mitsui To Form Thorne Asia JV

By Shivani Kumaresan

Today, 8:37 PM

Thorne HealthTech Inc (NASDAQ:THRN) has agreed to form a joint venture with Mitsui & Co Ltd (OTC:MITSY) called Thorne HealthTech Asia Pte. Ltd.…

MITSY

1 minute read

Thorne HealthTech And Mitsui Announce Thorne Asia Joint Venture

By Hal Lindon

Today, 8:37 PM

Thorne HealthTech, Inc. ("Thorne HealthTech" or "Thorne") (NASDAQ: THRN), a leader in developing innovative solutions for a personalized approach to health and wellbeing, today announced it has agreed to form a joint venture with Mitsui & Co., Ltd. ("Mitsui") called Thorne HealthTech Asia Pte. Ltd. ("Thorne Asia").

THRN

1 minute read

Trading Ideas

Watching Hyzon Motors, Nuvation Bio; Thorne HealthTech; Traders Circulate TipRanks Report ‘Billionaire Israel Englander Snaps Up These 3 “Strong Buy” Stocks’ Mentioning Stocks

By Benzinga Newsdesk

Today, 8:37 PM

https://blog.tipranks.com/billionaire-israel-englander-snaps-up-these-3-strong-buy-stocks/

HYZN

1 minute read

Thorne HealthTech Q3 EPS $0.01 Beats $(0.03) Estimate, Sales $48.01M Beat $45.35M Estimate

By Bill Haddad

Today, 8:37 PM

Thorne HealthTech (NASDAQ:THRN) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.03) by 133.33 percent. The company reported quarterly sales of $48.01 million which beat

THRN

18 minute read

Earnings Scheduled For November 10, 2021

By Benzinga Insights

Today, 8:37 PM

Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.

AACG

1 minute read

B of A Securities Initiates Coverage On Thorne HealthTech with Buy Rating, Announces Price Target of $11

By Benzinga Newsdesk

Today, 8:37 PM

B of A Securities initiates coverage on Thorne HealthTech (NASDAQ:THRN) with a Buy rating and announces Price Target of $11.

THRN

27 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For October 18, 2021

By Benzinga Insights

Today, 8:37 PM

Upgrades

AGRO

1 minute read

Evercore ISI Group Initiates Coverage On Thorne HealthTech with Outperform Rating, Announces Price Target of $13

By Benzinga Newsdesk

Today, 8:37 PM

Evercore ISI Group analyst Elizabeth Anderson initiates coverage on Thorne HealthTech (NASDAQ:THRN) with a Outperform rating and announces Price Target of $13.

THRN

1 minute read

Cowen & Co. Initiates Coverage On Thorne HealthTech with Outperform Rating, Announces Price Target of $11

By Benzinga Newsdesk

Today, 8:37 PM

Cowen & Co. analyst Oliver Chen initiates coverage on Thorne HealthTech (NASDAQ:THRN) with a Outperform rating and announces Price Target of $11.

THRN